Covalon Technologies Ltd. (CVE:COV – Get Free Report) traded up 18.6% during mid-day trading on Friday . The company traded as high as C$1.15 and last traded at C$1.15. 10,000 shares traded hands during mid-day trading, an increase of 73% from the average session volume of 5,786 shares. The stock had previously closed at C$0.97.
Covalon Technologies Stock Up 18.6 %
The company has a quick ratio of 6.45, a current ratio of 4.81 and a debt-to-equity ratio of 7.79. The firm has a market capitalization of C$28.37 million, a PE ratio of -6.05 and a beta of 0.55. The business’s 50-day moving average price is C$1.24 and its 200-day moving average price is C$1.18.
Covalon Technologies (CVE:COV – Get Free Report) last issued its earnings results on Wednesday, February 28th. The company reported C($0.03) earnings per share for the quarter. Covalon Technologies had a negative return on equity of 23.98% and a negative net margin of 19.67%. The firm had revenue of C$4.66 million during the quarter. As a group, equities research analysts predict that Covalon Technologies Ltd. will post 0.3 EPS for the current fiscal year.
About Covalon Technologies
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
Further Reading
- Five stocks we like better than Covalon Technologies
- There Are Different Types of Stock To Invest In
- 3 Stocks Leading the U.S. Agriculture Comeback
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- How to Use the MarketBeat Stock Screener
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
